(Q42620850)

English

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

scientific article published on February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

primary biliary cholangitis

0 references

1 reference

based on heuristic

inferred from title

M. Eric Gershwin

11

object named as

M Eric Gershwin

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

3

object named as

Zhe-Xiong Lian

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Christopher L Bowlus

12

object named as

Christopher L Bowlus

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

4

object named as

Weici Zhang

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

2

object named as

Yuki Moritoki

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

10

object named as

Keith Lindor

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1

object named as

Masanobu Tsuda

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Katsunori Yoshida

5

object named as

Katsunori Yoshida

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Kanji Wakabayashi

6

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Guo-Xiang Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Toshio Nakatani

8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

John Vierling

9

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

language of work or name

0 references

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

512-521

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

The causes of primary biliary cirrhosis: Convenient and inconvenient truths

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Treatment of childhood autoimmune haemolytic anaemia with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Identification and characterization of circulating human transitional B cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

CD3 antigen-mediated calcium signals and protein kinase C activation are higher in CD45R0+ than in CD45RA+ human T lymphocyte subsets

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

A critical role for B cells in the development of memory CD4 cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Effector and regulatory B cells: modulators of CD4+ T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

B cell depletion therapy exacerbates murine primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Connective tissue diseases: The conundrum of B cell depletion in SLE

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

21 January 2018

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab exerts a dual effect in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24748

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24748

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42620850&oldid=2198124254"